Lobbying client · LD-2 disclosures
Peck Madigan Jones (on Behalf of Acadia Pharmaceuticals, Inc.)
District of Columbia
2 filings from 1 registrant · 2020–2021 · latest filed Mar 17, 2021
Reported on its behalf
$20K
every LD-2 on file
Its own filed spend
$0
lobbying for itself
Fees to outside firms
$20K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
Who did the lobbying
Every lobbyist named on this client's filings.
- JAMES BRYANT HALL ii Tiber Creek Health Strategies, Inc.Covered position: Staff Director, Senate Veterans Affairs Committee; Legislative Director, Senator Bob Graham.1 filingthrough 2020
Covered positions · 1 of 1 lobbyists named on these filings disclosed a prior government post. The text is reproduced exactly as filed.
The filings
Every filing on record. Each row links to its full disclosure.
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: peck-madigan-jones-on-behalf-of-acadia-pharmaceuticals-inc.